We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Click here to add this to my saved trials
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Updated: 5/6/2013
A Long-acting Human Growth Hormone (VRS-317) in Pre-pubertal Children With Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy After Subcutaneous Administration for 6 Months
Status: Enrolling
Updated: 5/6/2013
Click here to add this to my saved trials
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
Updated: 5/8/2013
Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
Status: Enrolling
Updated: 5/8/2013
Effects of Naturally Silicon-Rich Water on Bone Metabolism in Women
Updated: 5/8/2013
Effects of Naturally Occurring Silicon in Drinking Water on Bone Metabolism
Status: Enrolling
Updated: 5/8/2013
Click here to add this to my saved trials
Adult Growth Hormone Deficiency and Cardiovascular Risk
Updated: 5/14/2013
Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
Status: Enrolling
Updated: 5/14/2013
Adult Growth Hormone Deficiency and Cardiovascular Risk
Updated: 5/14/2013
Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
A Study of Adalimumab to Treat Sarcoidosis of the Skin
Updated: 5/20/2013
A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
Status: Enrolling
Updated: 5/20/2013
A Study of Adalimumab to Treat Sarcoidosis of the Skin
Updated: 5/20/2013
A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous Sarcoidosis
Status: Enrolling
Updated: 5/20/2013
Click here to add this to my saved trials
Effects of Aerobic Exercise in Patients With Pre-diabetes
Updated: 5/20/2013
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated: 5/20/2013
Effects of Aerobic Exercise in Patients With Pre-diabetes
Updated: 5/20/2013
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated: 5/20/2013
Click here to add this to my saved trials
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
Updated: 5/30/2013
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated: 5/30/2013
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)
Updated: 5/30/2013
"Safety and Efficacy of Acthar Gel on Albuminuria and Urinary Transforming Growth Factor Excretion in Type I or Type II Diabetics Requiring Medical Treatment of Hyperglycemia With Nephrotic Range Proteinuria: A Pilot Study"
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Updated: 5/30/2013
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Updated: 5/30/2013
An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Status: Enrolling
Updated: 5/30/2013
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Updated: 5/30/2013
An Open Label, Non-Randomized, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Placebo-Controlled, Randomized Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Status: Enrolling
Updated: 5/30/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism
Updated: 6/4/2013
A 12 Month, Single Blind, Placebo Controlled, Phase III Study to Assess the Effects of Enclomiphene Citrate Treatment On Bone Mineral Density in Men With Secondary Hypogonadism
Status: Enrolling
Updated: 6/4/2013
Click here to add this to my saved trials
Safety Study of Abatacept to Treat Refractory Sarcoidosis
Updated: 6/10/2013
Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
Status: Enrolling
Updated: 6/10/2013
Safety Study of Abatacept to Treat Refractory Sarcoidosis
Updated: 6/10/2013
Sarcoidosis, Trial of Abatacept in Refractory Disease (STAR). A Prospective Open-Label Trial of Abatacept in Progressive Sarcoidosis
Status: Enrolling
Updated: 6/10/2013
Click here to add this to my saved trials
Effects of Standing on Glycemia in Prediabetic Adults
Updated: 6/21/2013
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated: 6/21/2013
Effects of Standing on Glycemia in Prediabetic Adults
Updated: 6/21/2013
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated: 6/21/2013
Click here to add this to my saved trials
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Updated: 6/25/2013
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Status: Enrolling
Updated: 6/25/2013
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Updated: 6/25/2013
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Status: Enrolling
Updated: 6/25/2013
Click here to add this to my saved trials
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Updated: 7/8/2013
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated: 7/8/2013
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Updated: 7/8/2013
Insulin Resistance in Non-alcoholic Fatty Liver Disease (Protocol Drug Change From Project CDA-2-044-08S)
Status: Enrolling
Updated: 7/8/2013
Click here to add this to my saved trials
Does Class of Dietary Fat Affect Insulin Resistance?
Updated: 7/11/2013
Insulin Resistance and Dietary Fat
Status: Enrolling
Updated: 7/11/2013
Does Class of Dietary Fat Affect Insulin Resistance?
Updated: 7/11/2013
Insulin Resistance and Dietary Fat
Status: Enrolling
Updated: 7/11/2013
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Click here to add this to my saved trials
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Updated: 7/18/2013
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors.
Status: Enrolling
Updated: 7/18/2013
Click here to add this to my saved trials
Moderate Intensity Exercise and Phenylketonuria
Updated: 7/19/2013
The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/19/2013
Moderate Intensity Exercise and Phenylketonuria
Updated: 7/19/2013
The Effects of an Acute Bout of Moderate Intensity Exercise on Plasma Amino Acids in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/19/2013
Click here to add this to my saved trials
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Updated: 8/6/2013
Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
Status: Enrolling
Updated: 8/6/2013
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Updated: 8/6/2013
Acute Impact of Antipsychotics on Insulin Sensitivity: A Novel Human Model
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
Updated: 8/6/2013
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated: 8/6/2013
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
Updated: 8/6/2013
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated: 8/6/2013
Click here to add this to my saved trials
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
Updated: 8/8/2013
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
Status: Enrolling
Updated: 8/8/2013
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
Updated: 8/8/2013
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia in Patients With Type 1 Diabetes in a Clinical Research Setting
Status: Enrolling
Updated: 8/8/2013
Click here to add this to my saved trials
Regulating Efficacy and Wellness in Diabetes
Updated: 8/9/2013
Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
Status: Enrolling
Updated: 8/9/2013
Regulating Efficacy and Wellness in Diabetes
Updated: 8/9/2013
Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes
Status: Enrolling
Updated: 8/9/2013
Click here to add this to my saved trials
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
Updated: 8/14/2013
An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 8/14/2013
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
Updated: 8/14/2013
An Open Label Study to Evaluate the Pharmacokinetics and Safety Profile of Androxal in Male Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 8/14/2013
Click here to add this to my saved trials
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Updated: 8/27/2013
Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome
Status: Enrolling
Updated: 8/27/2013
Click here to add this to my saved trials
Effect of Exercise on Insulin Resistance
Updated: 9/10/2013
Effect of Exercise on Insulin Resistance
Status: Enrolling
Updated: 9/10/2013
Effect of Exercise on Insulin Resistance
Updated: 9/10/2013
Effect of Exercise on Insulin Resistance
Status: Enrolling
Updated: 9/10/2013
Click here to add this to my saved trials
Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria
Status: Enrolling
Updated: 9/12/2013
Updated: 9/12/2013
Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria
Status: Enrolling
Updated: 9/12/2013
Updated: 9/12/2013
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels
Updated: 9/13/2013
A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Explore the Impact of Testosterone Solution 2% on Symptoms of Ejaculatory Dysfunction in Men With Testosterone Deficiency
Status: Enrolling
Updated: 9/13/2013
Click here to add this to my saved trials
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Updated: 9/17/2013
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated: 9/17/2013
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Updated: 9/17/2013
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
Status: Enrolling
Updated: 9/17/2013
Click here to add this to my saved trials
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
Updated: 10/5/2013
Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
Status: Enrolling
Updated: 10/5/2013
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
Updated: 10/5/2013
Effects of Pharmacologic Block of Type-1 Deiodinase on Thyroid Hormone Action and on the Circulating Levels of T3 in Hypothyroid Patients
Status: Enrolling
Updated: 10/5/2013
Click here to add this to my saved trials
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Updated: 10/23/2013
Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
Status: Enrolling
Updated: 10/23/2013
Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency
Updated: 10/23/2013
Effects of Pegvisomant-Priming With the Glucagon Stimulation Test in Assessing GH and Cortisol Reserve in Adults: a Randomized Proof-of-Concept Pilot Study
Status: Enrolling
Updated: 10/23/2013
Click here to add this to my saved trials
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Updated: 10/24/2013
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated: 10/24/2013
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Updated: 10/24/2013
Study of Triple Blockade of the Renin Angiotensin Aldosterone System (RAAS) in Diabetic (Type 1&2) Proteinuric Patients With (ACE-, ARB, DRI)
Status: Enrolling
Updated: 10/24/2013
Click here to add this to my saved trials